Ionis Pharmaceuticals Inc
IONS· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $167.79M | $160.35M | $51.57M | $84.86M |
| Net Income | -$2.92M | $25.87M | -$71.43M | $31.05M |
| EPS Diluted | -$0.03 |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| $0.21 |
| -$0.59 |
| $0.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.